Rapport Therapeutics, Inc. ($RAPP)
Bredt David โ Chief Scientific Officer
Shares
6,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Bredt David |
|---|---|
| Title | Chief Scientific Officer |
| Transaction Date | Feb 19, 2026 |
| Expiration Date | Dec 5, 2033 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Options (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Feb 20, 2026 |
| Document Date | Feb 17, 2026 |
| Shares Purchased | 6,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 88,080 |
| Derivative | Derivative |
| Accession Number | 0001193125-26-059883 |
| Document | View SEC Filing |